Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neurofibrosarcoma 1 Melanoma 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Doxorubicin 13 Gemcitabine 10 Cyclophosphamide 10 pazopanib 8 Filgrastim 8 Radiotherapy 7 Ifosfamide 7 Cisplatin 7 Irinotecan 6 Docetaxel 6 Radiation 5 Granulocyte Colony-Stimulating Factor 5 Etoposide 5 Trabectedin 4 Magnetic Resonance Spectroscopy 4 Celecoxib 4 Busulfan 4 Bevacizumab 4 Albumin-Bound Paclitaxel 4 temsirolimus 3 sargramostim 3 pembrolizumab 3 X-Rays 3 Sirolimus 3 Radiotherapy, Intensity-Modulated 3 Paclitaxel 3 Neoadjuvant Therapy 3 Leucovorin 3 Dexrazoxane 3 Cryosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Sarcoma × pexidartinib × Clear all

NCT02584647 2025-03-21

PLX3397

Columbia University

Phase 1/2 Terminated

39 enrolled 13 charts

Sarcoma, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡